Literature DB >> 9878555

Molecular cloning and expression of human grap-2, a novel leukocyte-specific SH2- and SH3-containing adaptor-like protein that binds to gab-1.

M Qiu1, S Hua, M Agrawal, G Li, J Cai, E Chan, H Zhou, Y Luo, M Liu.   

Abstract

The SH2- and SH3-containing adaptor molecules serve to recruit cytosolic signal-transducing molecules to the activated receptor tyrosine kinases. In this study, we report the molecular cloning of a novel adaptor-like protein, Grap-2 (Grb-2 related adaptor protein 2), using the multisubstrate docking protein Gab-1 as bait in the yeast two-hybrid system. Sequence analysis revealed that Grap-2 contains a SH3-SH2-SH3 structure that has a high degree of sequence homology to those of the Grb-2 and Grap adaptor molecules. However, unlike in Grap and Grb-2, the SH2 and the C-terminal SH3 domains of Grap-2 are separated by a 120-amino-acid glutamine-rich sequence that shows no apparent homology to any known molecule or structural motif. The C-terminal SH3 domain of Grap-2 alone is sufficient to bind to Gab-1. Furthermore, Northern blot analysis demonstrated that Grap-2 has two major transcripts of 1.4 and 4.0 kb that can only be detected in tissues rich in leukocytes and in two leukemia cell lines. This highly restricted pattern of expression suggests that Grap-2 may participate in leukocyte-specific protein tyrosine kinase signaling. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9878555     DOI: 10.1006/bbrc.1998.9795

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Efficient T-cell receptor signaling requires a high-affinity interaction between the Gads C-SH3 domain and the SLP-76 RxxK motif.

Authors:  Bruce T Seet; Donna M Berry; Jonathan S Maltzman; Jacob Shabason; Monica Raina; Gary A Koretzky; C Jane McGlade; Tony Pawson
Journal:  EMBO J       Date:  2007-01-18       Impact factor: 11.598

2.  Identification of a phospholipase C-gamma1 (PLC-gamma1) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-gamma1 and NFAT.

Authors:  D Yablonski; T Kadlecek; A Weiss
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  The SH2 domain-containing proteins in 21 species establish the provenance and scope of phosphotyrosine signaling in eukaryotes.

Authors:  Bernard A Liu; Eshana Shah; Karl Jablonowski; Andrew Stergachis; Brett Engelmann; Piers D Nash
Journal:  Sci Signal       Date:  2011-12-06       Impact factor: 8.192

4.  Induced expression and association of the Mona/Gads adapter and Gab3 scaffolding protein during monocyte/macrophage differentiation.

Authors:  Caroline Bourgin; Roland P Bourette; Sylvie Arnaud; Yan Liu; Larry R Rohrschneider; Guy Mouchiroud
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

5.  Grap negatively regulates T-cell receptor-elicited lymphocyte proliferation and interleukin-2 induction.

Authors:  Randy Shen; Ying-Bin Ouyang; Cheng-Kui Qu; Andres Alonso; Lindsey Sperzel; Tomas Mustelin; Mark H Kaplan; Gen-Sheng Feng
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

6.  Structural basis for SH3 domain-mediated high-affinity binding between Mona/Gads and SLP-76.

Authors:  Maria Harkiolaki; Marc Lewitzky; Robert J C Gilbert; E Yvonne Jones; Roland P Bourette; Guy Mouchiroud; Holger Sondermann; Ismail Moarefi; Stephan M Feller
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

7.  Grf40, A novel Grb2 family member, is involved in T cell signaling through interaction with SLP-76 and LAT.

Authors:  H Asada; N Ishii; Y Sasaki; K Endo; H Kasai; N Tanaka; T Takeshita; S Tsuchiya; T Konno; K Sugamura
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

Review 8.  Bridging the Gap: Modulatory Roles of the Grb2-Family Adaptor, Gads, in Cellular and Allergic Immune Responses.

Authors:  Deborah Yablonski
Journal:  Front Immunol       Date:  2019-07-25       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.